This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovations of Hans J Hoeltke
Introduction
Hans J Hoeltke is a notable inventor based in Tutzing, Germany. He has made significant contributions to the field of molecular biology, particularly in the development of restriction endonucleases. His work has implications for genetic research and biotechnology.
Latest Patents
One of Hoeltke's key patents is the Type II restriction endonuclease McrI. This endonuclease has a specific recognition sequence wherein R is G or A and Y is C or T. The cleavage site is indicated by arrows in the patent documentation. The endonuclease is preferably obtained from organisms of the genus Micrococcus. It can be utilized to recognize and cleave double-stranded DNA sequences, making it a valuable tool in genetic engineering.
Career Highlights
Hoeltke is associated with Boehringer Mannheim GmbH, a company known for its advancements in biotechnology and pharmaceuticals. His work at the company has allowed him to focus on innovative solutions in molecular biology.
Collaborations
Throughout his career, Hoeltke has collaborated with several esteemed colleagues, including Michael Jarsch and Gudrun Schmitz-Agheguian. These collaborations have furthered research and development in the field.
Conclusion
Hans J Hoeltke's contributions to the field of molecular biology, particularly through his patent for the Type II restriction endonuclease McrI, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the landscape of genetic research and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile